Wells Fargo Adds Aerovate Therapeutics Inc (AVTE) to Q2 '24 Tactical Ideas List
Tweet Send to a Friend
Wells Fargo analyst Tiago Fauth reiterated an Overweight rating and $35.00 price target on Aerovate Therapeutics Inc (NASDAQ: AVTE).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
